We recently published 10 Stocks Exploded Over 100%; One Shockingly Soared 11,000%. Regencell Bioscience Holdings Limited (NASDAQ:RGC) is one of the top-performing mid-cap companies of the first half of the year.
Regencell Bioscience soared by a whopping 11,661 percent year-to-date, finishing at $15.29 on Wednesday after trading below the minimum bid price requirement of $1 in most of its days as a publicly listed company.
The mysterious rally can be attributed to a reverse-stock split, which officially took effect last mont,h where Regencell Bioscience Holdings Limited implemented a 38-to-1 stock split that sent its price percentage change soaring.
According to the company, the move was intended to “enhance liquidity in the market for the company’s ordinary shares and make the shares more accessible to investors.”
A research scientist studying a microscope in a discovery lab to develop new immunomedicines.
Regencell Bioscience Holdings Ltd. is a Hong Kong-based company that uses traditional Chinese medicine to treat Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
